Altre lingue KPC Pharmaceuticals,Inc

Azioni

600422

CNE0000015P8

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
22,72 ^CNY	-0,66%		+8,76%	+8,92%

19/04	KPC Pharmaceuticals,Inc riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
21/03	KPC Pharmaceuticals,Inc riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Kunyao Group Receives Clinical Trial Approval for FMF Drug	17/04
KPC Pharmaceuticals,Inc Proposes Cash Dividend	21/03
KPC Pharmaceuticals,Inc Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
KPC Pharmaceuticals,Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
KPC Pharmaceuticals’ Antimalarial Drug Passes WHO Prequalification	13/10/23
KPC Pharmaceuticals' Attributable Profit Rises 3.1%; Shares Slip 4%	30/08/23
KPC Pharmaceuticals,Inc Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
KPC Pharmaceuticals' Q1 Net Profit Jumps; Shares Rise 7%	28/04/23
KPC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
KPC Pharma’s Shingles Drug Added to China’s Medical Insurance Catalog	20/01/23
KPC Pharma to Hold Phase II Clinical Trial of Stroke Drug	20/01/23
China Resources Pharmaceutical Completes Transfer of KPC Pharmaceutical Shares to Unit	03/01/23
KPC Pharmaceuticals CFO Steps Down	02/01/23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. completed the acquisition of a 28% stake in KPC Pharmaceuticals, Inc. from Hofon Pharmaceuticals Co.,Ltd. and Holley Group Company Limited.	30/12/22
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22
KPC Pharmaceuticals Unit Receives Marketing Authorization of Angong Niuhuang Pills; Shares Jump 7%	21/10/22
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	15/08/22
Chinese Shares Rebound; KPC Pharma Rallies 10% on CR Sanjiu’s $431 Million Stake Purchase	10/05/22
CR Sanjiu Medical & Pharma to Buy 28% Stake in KPC Pharma For $430 Million	10/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue KPC Pharmaceuticals,Inc

Azioni

600422

CNE0000015P8

Altre lingue

Filtri